Position in TRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$196,123
-$7,092 QoQ
Shares Held
10,516
-38.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#162
of 216 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. TRVI ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
676,247 | $335,912,169 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
382,028 | $238,209,735 | |
| 3 | INCY |
Incyte Corp
|
1,307,743 | $148,245,744 | |
| 4 | RPRX |
Royalty Pharma plc
|
1,224,925 | $68,681,542 | |
| 5 | MRNA |
Moderna, Inc.
|
636,199 | $44,553,014 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
115,279 | $34,702,435 | |
| 7 | INSM |
INSMED Inc
|
279,961 | $29,849,438 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
307,543 | $17,597,610 |
All Filings in TRVI
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $196,123 | 10,516 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $203,215 | 17,034 | Shares | Defined | 2026-04-30 | |
| 2025-09-30 | $380,951 | 41,634 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $341,541 | 62,439 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $174,534 | 27,748 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $184,382 | 44,753 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,659 | 43,910 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $58,443 | 19,612 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||